To evaluate the role of retinopexy in the surgical management of primary rhegmatogenous retinal detachment (RD) without proliferative vitreoretinopathy. The primary outcome was retinal attachment, and secondary outcomes were visual acuity results and complications.
A randomized controlled trial including 60 patients with RD caused by a break or a group of breaks no larger than one clock hour. Thirty eyes received no retinopexy (group 1), and 30 eyes received transscleral cryotherapy (group 2). An encircling buckle was placed in all eyes. In eyes with posterior breaks, segmental buckles were also added. In some eyes, subretinal fluid drainage or anterior chamber paracentesis and/or intravitreal air bubble injection was performed.
No differences were found between the groups in terms of the preoperative clinical variables evaluated: age; sex; axial length; lens status; type, number, and location of breaks; extension of detachment; and macula status. There were no differences in the surgical procedures performed. The reattachment rate in group 1 was 90%, and in group 2, it was 87% (a difference that was not significant [P = 1.00]). Final visual acuity improved by two lines or more in 22 patients in group 1 and in 20 patients in group 2 (P = 0.317).
Our results indicate that primary rhegmatogenous RD can be successfully treated with scleral buckling without retinopexy.
*Department of Ophthalmology, Ramon y Cajal University Hospital, Madrid, Spain; and the †Eye Clinic, University of Naples; and ‡Hospital San Camilo, Rome, Italy.
Reprint requests: Marta S. Figueroa, MD, PhD, Hospital Universitario Ramon y Cajal, Departamento de Oftalmología, Unidad de Vítreo y Retina, Carretera de Colmenar Km 9, 28034 Madrid, Spain.
The authors have no commercial interests or proprietary interest in the materials presented in this article.
Presented in part at the meeting of the American Academy of Ophthalmology; Dallas, TX; October 2000.